BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 38636499)

  • 1. Usefulness of cancer-free survival in estimating the lifetime attributable risk of cancer incidence from radiation exposure.
    Seo S; Lee DN; Jin YW; Lee WJ; Park S
    J Radiol Prot; 2018 Sep; 38(3):N17-N24. PubMed ID: 29749344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.
    ; Fitzmaurice C; Allen C; Barber RM; Barregard L; Bhutta ZA; Brenner H; Dicker DJ; Chimed-Orchir O; Dandona R; Dandona L; Fleming T; Forouzanfar MH; Hancock J; Hay RJ; Hunter-Merrill R; Huynh C; Hosgood HD; Johnson CO; Jonas JB; Khubchandani J; Kumar GA; Kutz M; Lan Q; Larson HJ; Liang X; Lim SS; Lopez AD; MacIntyre MF; Marczak L; Marquez N; Mokdad AH; Pinho C; Pourmalek F; Salomon JA; Sanabria JR; Sandar L; Sartorius B; Schwartz SM; Shackelford KA; Shibuya K; Stanaway J; Steiner C; Sun J; Takahashi K; Vollset SE; Vos T; Wagner JA; Wang H; Westerman R; Zeeb H; Zoeckler L; Abd-Allah F; Ahmed MB; Alabed S; Alam NK; Aldhahri SF; Alem G; Alemayohu MA; Ali R; Al-Raddadi R; Amare A; Amoako Y; Artaman A; Asayesh H; Atnafu N; Awasthi A; Saleem HB; Barac A; Bedi N; Bensenor I; Berhane A; Bernabé E; Betsu B; Binagwaho A; Boneya D; Campos-Nonato I; Castañeda-Orjuela C; Catalá-López F; Chiang P; Chibueze C; Chitheer A; Choi JY; Cowie B; Damtew S; das Neves J; Dey S; Dharmaratne S; Dhillon P; Ding E; Driscoll T; Ekwueme D; Endries AY; Farvid M; Farzadfar F; Fernandes J; Fischer F; G/Hiwot TT; Gebru A; Gopalani S; Hailu A; Horino M; Horita N; Husseini A; Huybrechts I; Inoue M; Islami F; Jakovljevic M; James S; Javanbakht M; Jee SH; Kasaeian A; Kedir MS; Khader YS; Khang YH; Kim D; Leigh J; Linn S; Lunevicius R; El Razek HMA; Malekzadeh R; Malta DC; Marcenes W; Markos D; Melaku YA; Meles KG; Mendoza W; Mengiste DT; Meretoja TJ; Miller TR; Mohammad KA; Mohammadi A; Mohammed S; Moradi-Lakeh M; Nagel G; Nand D; Le Nguyen Q; Nolte S; Ogbo FA; Oladimeji KE; Oren E; Pa M; Park EK; Pereira DM; Plass D; Qorbani M; Radfar A; Rafay A; Rahman M; Rana SM; Søreide K; Satpathy M; Sawhney M; Sepanlou SG; Shaikh MA; She J; Shiue I; Shore HR; Shrime MG; So S; Soneji S; Stathopoulou V; Stroumpoulis K; Sufiyan MB; Sykes BL; Tabarés-Seisdedos R; Tadese F; Tedla BA; Tessema GA; Thakur JS; Tran BX; Ukwaja KN; Uzochukwu BSC; Vlassov VV; Weiderpass E; Wubshet Terefe M; Yebyo HG; Yimam HH; Yonemoto N; Younis MZ; Yu C; Zaidi Z; Zaki MES; Zenebe ZM; Murray CJL; Naghavi M
    JAMA Oncol; 2017 Apr; 3(4):524-548. PubMed ID: 27918777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A framework for estimating radiation-related cancer risks in Japan from the 2011 Fukushima nuclear accident.
    Walsh L; Zhang W; Shore RE; Auvinen A; Laurier D; Wakeford R; Jacob P; Gent N; Anspaugh LR; Schüz J; Kesminiene A; van Deventer E; Tritscher A; del Rosarion Pérez M
    Radiat Res; 2014 Nov; 182(5):556-72. PubMed ID: 25251702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 DALYs and HALE Collaborators
    Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019.
    Safiri S; Kolahi AA; Naghavi M;
    BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34844997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of lifetime mortality risk, incidence risk, and DALYs of baseline cancer rates among countries as a benchmark for radiation-related cancer risk.
    Hirouchi J; Kujiraoka I; Takahara S; Takada M; Schneider T; Kai M
    J Radiol Prot; 2024 Apr; 44(2):. PubMed ID: 38636499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose response and temporal patterns of radiation-associated solid cancer risks.
    Preston DL; Pierce DA; Shimizu Y; Ron E; Mabuchi K
    Health Phys; 2003 Jul; 85(1):43-6. PubMed ID: 12852470
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.